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gal-1 (galectin-1) mediates cell–cell and cell–extracellular matrix
adhesion,essentiallybyinteractingwithβ-galactoside-containing
glycansofcell-surfaceglycoconjugates.Althoughmoststructural
studies with gal-1 have investigated its binding to simple carbo-
hydrates,inparticularlactoseandN-acetyl-lactosamine,thisview
islimited,becausegal-1functionsatthecellsurfacebyinteracting
with more complex glycans that are heterogeneous in size and
composition. In the present study we used NMR spectroscopy
to investigate the interaction of human gal-1 with a large
(120 kDa) complex glycan, GRG (galactorhamnogalacturonate
glycan), that contains non-randomly distributed mostly terminal
β(1→4)-linked galactose side chains. We used
15N–
1H-HSQC
(heteronuclearsinglequantumcoherence)NMRexperimentswith
15N-enriched gal-1 to identify the GRG-binding region on gal-1
and found that this region covers a large surface area on gal-1 that
includes the quintessential lactose-binding site and runs from
thatsitethroughabroadvalleyorclefttowardsthedimerinterface.
HSQCandpulsed-ﬁeld-gradientNMRdiffusionexperimentsalso
show that gal-1 binds GRG with a gal-1:GRG stoichiometry of
about 5:1 (or 6:1) and with average macroscopic and microscopic
equilibrium dissociation constants (Kd)o f8 ×10
−6 Ma n d
40×10
−6 M (or 48×10
−6 M) respectively, indicating stronger
binding than to lactose (Kd =520×10
−6 M). Although gal-1
may bind GRG in various ways, the glycan can be competed
for by lactose, suggesting that there is one major mode of
interaction. Furthermore, even though terminal motifs on GRG
are Gal-β(1→4)-Gal rather than the traditional Gal-β(1→4)-
Glc/GlcNAc (where GlcNAc is N-acetylglucosamine), we show
that the disaccharide Gal-β(1→4)-Gal can bind gal-1 at the
lactose-binding domain. In addition, gal-1 binding to GRG
disrupts inter-glycan interactions and decreases glycan-mediated
solution viscosity, a glycan decongestion effect that may help
explain why gal-1 promotes membrane ﬂuidity and lateral
diffusion of glycoconjugates within cell membranes. Overall, our
results provide an insight into the function of galectin in situ and
have potential signiﬁcant biological consequences.
Key words: carbohydrate-binding domain, cell surface, galectin–
glycan interactions, heteronuclear single quantum coherence
nuclear magnetic resonance (HSQC NMR), NMR diffusion
spectroscopy, simple saccharide.
INTRODUCTION
Traditionally, galectins have been deﬁned as a subfamily of
lectins that selectively bind β-galactosides, and all galectins
share signiﬁcant amino acid sequence conservation within their
CRD (carbohydrate-recognition domain) [1]. Although galectins
in general can have intracellular functions (e.g. modulating
proliferation, apoptosis and pre-mRNA splicing), they are best
known for their extracellular activities in mediating cell–cell and
cell–matrix adhesion and migration by interacting with various
glycangroupsofcell-surfaceglycoproteinsand/orglycolipids[2].
gal-1(galectin-1)interactswithvariousglycoconjugateligandsof
the extracellular matrix [e.g. laminin, ﬁbronectin, the β1 subunit
of integrins, ganglioside GM1 and the Lamps (lysosomal-mem-
brane-associated proteins) Lamp 1 and Lamp 2)], as well as
those on endothelial cells {e.g. integrins αvβ3 and αvβ5, ROBO4
[roundabout homologue 4, magic roundabout (Drosophila)],
CD36, and CD13} and on T-lymphocytes (e.g. CD7, CD43,
and CD45), where it is known to induce apoptosis [2]. Their
binding to glycans of cell-surface glycoconjugates can also
trigger intracellular activity. For example, gal-1 interacts with
the α5β1 ﬁbronectin receptor to restrict carcinoma cell growth
via induction of p21 and p27 {Ras–MEK–ERK [Ras GTPase–
MAPK (mitogen-activated protein kinase)/ERK (extracellular-
signal-regulated kinase) kinase–ERK]} pathway [3].
The disaccharide lactose (Gal-β(1→4)-Glc) is the simplest
carbohydrate to which galectins bind and one that has been
used most often to delineate galectin function and structure–
activity relationships in vitro [1]. High-resolution structures of
glycan–galectin interactions have been limited to galectin bound
to lactose, N-acetyl-lactosamine, trisaccharide and an N-acetyl-
lactosamineoctasaccharide[4].Inallthesecases,aβ-galactoside-
containing disaccharide moiety is shown to bind galectin in
a similar fashion at its classical CRD, i.e. the quintessential
lactose-binding domain, and even the largest one, N-acetyl-lacto-
samine octasaccharide, has the remaining six saccharide units
jutting out from the galectin CRD into solution. Although
providing a structural insight into gal-1 saccharide binding, pre-
vious studies have provided a biased picture of how galectins
interact with, and affect, the properties of complex, hetero-
geneous cell-surface glycans. Actual galectin-binding glycans of
various glycoconjugates in situ have far more varied saccharide
compositions and complicated structures than the simple
saccharides mentioned above, as they are larger, heterogeneous
Abbreviations used: CRD, carbohydrate-recognition domain; ERK, extracellular-signal-regulated kinase; gal-1, galectin-1; GRG, galactorhamnogalact-
uronate glycan [α-(1→2)-l-rhamnosyl-α-(1→4)-D-galacturonosyl]; HSQC, heteronuclear single quantum coherence; Lamp, lysosomal-membrane-
associated protein; PFG, pulsed-ﬁeld gradient.
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in size and composition, densely packed and therefore self-
associating, and it is likely that gal-1 interacts to some extent
with saccharide units other than β-galactose in those glycans
[5]. The relatively low intrinsic binding afﬁnity (micro- to milli-
molar)ofsimplesaccharidestogalectinsissigniﬁcantlyincreased
by multivalent interactions with larger glycan ligands. Moreover,
gal-1, like most galectins, is a dimer with two CRDs that can
mediateintermolecularglycancross-linking[6].Allthisandmore
could determine and/or differentiate galectin structure–function
relationships.
In the present paper we report on NMR experiments with
humangal-1anditsinteractionswithGRG(galactorhamnogalact-
uronate glycan), a relatively large heterogeneous glycan derived
from citrus pectins. Citrus pectins are branched heteropoly-
saccharides of various molecular masses ranging from about
40 kDa to several million Da, and contain multiple branches
of oligosaccharides comprised of one to 20 or more moieties of
galacturonate,arabinose,galactose,glucose,xylose,mannoseetc.
[7]. These complex glycans can also include single residues
or chains of uronic acid, and their carboxylic groups can be
esteriﬁed to the extent of 2–30%. Owing to their large size, these
glycans tend to form gels in solution [8]. Following processing,
the GRG has a weight-average molecular mass of about 120 kDa
[9] and can be characterized as having an irregular structure
with ﬁve principal components: rhamnose, fucose, arabinose,
galactose and uronate, which by weight account for about 4.3,
3.7, 19, 37 and 36% respectively [10,11]. The backbone of the
GRG polymer is mainly composed of α-(1→2)-L-rhamnosyl-
α-(1→4)-D-galacturonosyl sections. As with most complex
glycans, precise structural details for GRG are lacking. However,
it is known that the galactose side-chains in GRG are randomly
distributed via β(1→4) linkages, most of which are at terminal
positions [7,10,12], suggesting the potential for interactions with
galectins.
In this regard, pectin-derived polysaccharides have been
reported to interact with gal-3 [13], as well as to inhibit human
cancer cell growth and metastasis in mice [14] and to enhance
apoptosis in human prostrate-cancer cells [15] and multiple
myeloma cells in vitro, probably also by interacting with, and
antagonizing, the function of gal-3 and possibly that of other
galectins[16].GRGiscurrentlybeinginvestigatedanddeveloped
as a therapeutic in the oncology arena. Here, we demonstrate
that GRG interacts with gal-1 over a large surface area on the
protein that includes the quintessential lactose-binding site and
runs from that site through a broad valley or cleft towards the
dimer interface. We also show that binding of gal-1 to GRG
disrupts inter-glycan interactions and decreases glycan-mediated
solution viscosity, which may help explain previous ﬁndings that
gal-1 promotes increased membrane ﬂuidity and lateral diffusion
of glycoconjugates within cell membranes. Overall, our results
provide a novel picture of gal-1 binding to a relatively complex
glycan, as well as an insight into galectin structure–function
relationships with potential signiﬁcant biological consequences.
MATERIALS AND METHODS
Gal-1 preparation
Uniformly
15N-labelled gal-1 was expressed in Escherichia
coli BL21(DE3) competent cells (Novagen) grown in minimal
medium. It was puriﬁed over a β-lactose afﬁnity column, and
further fractionated on a gel-ﬁltration column as described
previously [17]. Typically, 44 mg of puriﬁed protein were
obtained from 1 litre of cell culture. The purity of the ﬁnal
sample was quantiﬁed by using the Bio-Rad protein assay and
was checked for purity by SDS/PAGE. The functional activity of
the puriﬁed protein was assessed by using a T-cell death assay.
Glycan preparation
GRG was produced from crude citrus pectins that were de-
creased in size to increase solubility and expose galactose resi-
dues for potentially better interactions with gal-1. The
glycan size-reduction protocol used controlled conditions
(temperature, reaction time, catalysts) with hydrogen peroxide
and L-ascorbate to catalytically hydrolyse glycosidic linkages
in the polysaccharide backbone and oligosaccharide side
chains into smaller polysaccharide molecules [10,11]. This
chemical modiﬁcation was aimed at limited depolymerization
of the backbone of the polymer, mainly the α-(1→2)-L-
rhamnosyl-α-(1→4)-D-galacturonosyl sections, accompanied
by de-methoxylation and de-acetylation of carboxylic groups of
the polymer, which also decreased hydrophobicity, and hence
increased aqueous solubility. Brieﬂy, the crude commercially
available citrus pectin (provided as solid crude powder of
a kind typically used in food industry) was dissolved in
water to pH 10 with 3 M NaOH. After incubation at 50◦C
for 30 min, 20% (v/v) ethanol was added, and the partially
puriﬁed polysaccharide was precipitated to remove proteins and
pigments. The polysaccharide was then dissolved to 20 g/litre
in water, followed by addition of triﬂuoroacetic acid to a ﬁnal
concentration of 0.5 M for controlled de-polymerization in which
thegalactorhamnogalacturonanbackboneiscleavedtothedesired
size. After incubation for 24 h at 60◦C, the solution pH was
adjusted to 4. The solution was cooled to 4◦C and centrifuged
(15000 g for 60 min) to remove insoluble matter. The supernatant
was then neutralized to a ﬁnal pH of 8.0 with 1 M NaOH, and
20% ethanol was added to recover soluble polysaccharide. The
resulting soluble branched polysaccharide product (GRG) was
washed with 70% ethanol or with 100% acetone to provide a
ﬁnal dry powder.
HSQC (heteronuclear single quantum coherence)
NMR spectroscopy
Uniformly
15N-labelled gal-1 was dissolved at a concentration
of 0.3 mM in 20 mM potassium phosphate buffer, pH 7.0, and
0.8 mM dithiothreitol, made up using a
1H2O/
2H2O (9:1) mixture.
Using uniformly
15N-enriched gal-1, we performed HSQC NMR
experiments to investigate binding of gal-1 to GRG [17].
1H
and
15N resonance assignments for the gal-1 have already been
reported [17].
All NMR experiments were carried out at 30◦Co naV a r i a n
Unity Inova 600 MHz spectrometer equipped with an H/C/N
triple-resonance probe and x/y/z triple-axis PFG (pulsed-ﬁeld
gradient) unit. A gradient sensitivity-enhanced version of two-
dimensional
1H–
15N HSQC was applied with 256 (t1) x 2048
(t2) complex data points in nitrogen and proton dimensions
respectively. Raw data were converted and processed by using
NMRPipe [18] and were analysed by using NMRview [19].
PFG NMR self-diffusion measurements
For NMR measurements, gal-1 was dissolved in 0.6 ml of 20 mM
potassium phosphate buffer, pH 7.0, and 0.8 mM dithiothreitol,
madeupusing
2H2O,andthepHwasadjustedbyaddingmicrolitre
quantities of NaO
2Ho r
2HCl. PFG NMR self-diffusion measure-
ments were made on a Varian INOVA-600 spectrometer using a
GRASP
TM (gradient-acceleratedspectroscopy)unitaspreviously
described [20]. NMR spectra for measurement of diffusion coef-
ﬁcients, D, were acquired using a 5 mm triple-resonance probe
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Figure 1 1H-15N HSQC spectra for gal-1 with and without GRG
HSQC spectra are shown for 15N-enriched gal-1 (1mg/ml) alone (A) and at gal-1/GRG molar ratios of 20:1 (B) and 5:1 (C). Spectral expansions are provided below each plot to visualize better the
observed resonance broadening as GRG is added to the gal-1 solution. Resonances in the expansion plot to (A) are labelled with assignments reported by Nesmelova et al. [17]. H1, 1H; N15, 15N.
equipped with an actively shielded z-gradient coil. The maxi-
mum magnitude of the gradient was calibrated using the
manufacturer’s standard procedure based on the frequency spread
of the applied gradient and was found to be 100 G/cm. This was
consistent with the value of 98 G/cm obtained from analysis of
PFG data on water using its known diffusion constant [20]. The
linearity of the gradient was checked by performing diffusion
measurements on water over different ranges of the gradient.
The PFG longitudinal eddy-current delay pulse sequence [20]
was used for self-diffusion measurements, which were performed
in 20 mM potassium phosphate buffer, pH 7.0, and 0.8 mM
dithiothreitol, made up using
2H2O at a temperature of 30◦C.
For unrestricted diffusion of a molecule in an isotropic liquid,
the PFG NMR signal amplitude, A, normalized to the signal
obtained in the absence of gradient pulses, is related to D by
eqn (1):
A = exp[−γ
2g
2 
2D(  − γ/3)]
where γ is the gyromagnetic ratio of the observed nucleus, g and
δ are the magnitude and duration of the magnetic ﬁeld gradient
pulses respectively, and   is the time between the gradient pulses
[20]. For these experiments, δ =4 ms, g=1–75 G/cm,
 =34.2 ms, and the longitudinal eddy-current delay (Te) was
100 ms. Each D value was determined from a series of 12
one-dimensional PFG spectra acquired using different g values.
MeasurementsofDwerecalibratedbyperformingthePFGNMR
self-diffusion measurements on dextran standards and standard
proteins [9,21].
RESULTS
Gal-1 binds to GRG
Figure 1(A) shows a
1H–
15N HSQC spectrum of uniformly
15N-
enriched gal-1, with cross-peaks labelled as assigned previously
[17]. At this concentration (1 mg/ml; 70×10
−6 M), gal-1 with
a monomer↔dimer equilibrium dissociation constant (Kd)o f
about 2×10
−6 M[ 4 ] ,i s>99% dimer. As the concentration of
GRG is increased, gal-1 resonances are differentially broadened,
as exempliﬁed by the
15N-enriched gal-1 HSQC spectra acquired
at gal-1/GRG molar ratios of 20:1 and 5:1 (Figures 1B and 1C
respectively). Differential broadening is better appreciated in the
HSQC spectral expansions shown below each of the full spectra
in Figure 1. Because all three HSQC spectra were collected,
processedandplottedthesameway,itisapparentthatsomecross-
peaks have disappeared, some are greatly decreased in intensity
and others appear relatively less affected. These data alone indic-
ate that gal-1 interacts with GRG. Although the increased weight-
average molecular mass(es) of the complex(es) formed between
gal-1 and GRG likely contribute(s) somewhat to the observed
broadening of gal-1 resonances, most of this effect is the result of
exchange between or among gal-1 and binding sites on GRG that
is occurring on the intermediate chemical-shift time scale [22].
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Figure 2 Gal-1–GRG binding curve and HSQC resonance broadening
mapping
(A) The average of fractional changes for the 40 most broadened resonances is plotted against
the concentration (mg/ml) of GRG. Error bars represent S.D. The continuous line represents a
sigmoidal (Boltzmann) ﬁt using the general equation y =A ·ex/b through the average value
at each concentration point. The χ2 value for the ﬁt was <0.0005. (B) This plot shows initial
fractional changes in gal-1 resonance intensities observed at lower glycan/gal-1 molar ratios
(where most gal-1 resonances are still apparent) against the amino acid sequence of gal-1 for
GRG. A value of 1 indicates that the resonance associated with that particular residue is no
longer apparent, and a value of zero indicates no change in resonance intensity.
These HSQC data also indicate that the folded structure of
gal-1 dimer is not signiﬁcantly perturbed by binding to GRG. We
reached this conclusion because even though
1H–
15N resonances
are differentially broadened (intensities decreased) during the
titration, the chemical shifts of resonances remaining during
the titration are mostly unchanged.
Using our HSQC data, we could also estimate the gal-1–
GRG binding afﬁnity and stoichiometry by plotting the fractional
change in gal-1 HSQC resonance intensities as a function of the
concentration (mg/ml) of GRG (Figure 2A). Fractional changes
were calculated by subtracting from 1 the intensity of a given
HSQCcross-peakdividedbythatinpuregal-1atthesameprotein
concentration and with NMR data collected and processed the
same way. The average of fractional changes for the 40 most
broadenedresonancesisplottedasafunctionoftheconcentration
of GRG in Figure 2(A). S.D. values are indicated by error bars.
The continuous line represents a sigmoidal (Boltzmann) ﬁt
using the general equation:
y = A·e
x/b
(where y is fractional intensity, A is the signal amplitude, x is the
concentration of gRG and A and b are variable ﬁtting parameters)
through the average value at each concentration point. The χ
2
valuefortheﬁtwas<0.0005.AnapparentKd valuewasestimated
at the point on this curve where 50% of the gal-1 molecules are
bound to GRG. In this regard, the average fractional intensity
change of 0.5 (50% bound) occurs at a GRG concentration of
1 mg/ml, which corresponds to an apparent macroscopic Kd value
of about 8×10
−6 M when a weight-average molecular mass of
120 kDa was used for GRG [9]. Furthermore, because gal-1
at 1 mg/ml has about 70×10
−6 M in gal-1 CRD equivalents
(14500 Da), each average GRG molecule should saturate about
ﬁve gal-1 CRDs. This binding stoichiometry of 5:1 (gal-1/GRG)
would yield an average microscopic binding constant of about
40×10
−6 M/site.
GRG binding site on gal-1
Using these HSQC data, we also gained insight into where GRG
interacts on the surface of gal-1. We do this in a way that is
similartoHSQCchemical-shiftmapping[23],whichisperformed
when binding interactions occur in the fast or slow exchange
regimes on the chemical-shift time scale. In these instances,
resonances are chemically shifted, and little broadened, during
the titration with ligand. In our case, gal-1 resonances initially
may be shifted somewhat by interaction with GRG, but are
primarily broadened due to the exchange process which falls
in the intermediate exchange regime on the NMR chemical-
shift time scale [22]. There are a number of factors that can
contribute to a system falling into a particular NMR exchange
regime. However, the general tendency is that as the lifetime of
a complex is increased (i.e. binding becomes relatively stronger),
the exchange regime on the chemical-shift time scale goes from
fast to intermediate to slow. Because interactions occurring on
the intermediate exchange time scale may not show discrete
resonances, the way in which we present observed broadening
effects is different from the way in which we would show
1Ha n d
15N weighted average chemical-shift changes for a system in the
fast or slow exchange regimes.
In the intermediate exchange regime, we show differential
broadening at a molar ratio where most resonances are still
observed, but are at lower intensities, owing to the broadening.
We refer to this as ‘HSQC resonance broadening mapping’ in
order to distinguish it from ‘HSQC chemical-shift mapping’. The
interpretation is essentially the same as with HSQC chemical-
shift mapping, i.e. those resonances that are initially broadened
themostareassociatedwiththatsite(s)ongal-1thatinteractswith
GRG. We create this map by taking the initial fractional changes
ingal-1HSQCresonanceintensitiesobservedatalowGRG/gal-1
molar ratio (where most gal-1 resonances are still apparent) and
by plotting them against the amino acid sequence of gal-1. This
is illustrated in Figure 2(B), where a value of 1 indicates that
the resonance associated with that particular residue is no longer
apparent (highly broadened), and a value of 0 indicates no change
in resonance intensity (not broadened). From these data it is
apparent which gal-1 residues are initially more affected than
others.
Figure 3(A) highlights the most affected residues on the folded
structure of gal-1 dimer. Resonances whose fractional intensity
decrease is more than 0.8, or between 0.6 and 0.8 (Figure 2B),
are highlighted in red and orange respectively. The image on
the left illustrates the dimer surface with the lactose-binding
sites (one per monomer) oriented at the top left and bottom
right. For reference, lactose molecules are shown in blue at their
previously determined binding sites [24]. Clearly, gal-1 residues
at the quintessential lactose-binding site are affected by binding
toGRG.However,manyothergal-1residuesonthissamesurface
are also signiﬁcantly affected, indicating that GRG interacts with
a larger area on this surface of gal-1. By contrast, GRG binding
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Figure 3 The GRG binding site on gal-1
(A) Residues on the folded structure of gal-1 that have been most affected by binding to GRG
are highlighted in red and orange as discussed in the text. The X-ray structure of lactose-bound
human gal-1 has been used in this Figure (Protein Data Base access code: 1gzw) [24]. The
orientation at the left shows the face of the dimer where GRG binds. Bound lactose molecules
are shown in blue on the gal-1 dimer structure. The gal-1 dimer interface is also indicated. The
orientationattherightshowstheoppositesideofthedimerwherelactosebinds.(B)Illustrationof
gal-1residuesintheGRG-bindingdomain.Polar,positivelychargedandhydrophobicresidues
are colored in orange, blue, and green respectively. For reference, the lactose molecule in its
binding site is shown in purple. The one-letter code for amino acids is used (e.g. K28=Lys28
etc.).
also affects a few residues on the opposite surface of the gal-1
dimer (Figure 3A, right-hand image). Although the reason for
this is unclear, it may be that GRG interacts to some extent
with these residues, or, more likely, that GRG binding on the
front surface (Figure 3A, left-hand image) perturbs NH groups
on the opposite face through the β-sheet sandwich. Furthermore,
this novel extended glycan-binding domain on gal-1 could be
explained by various modes of interaction with binding sites
on heterogeneous GRG. However, when we add a large molar
excess of lactose (200 mM), the NMR spectral effects on gal-1
from GRG binding can be reversed, indicating that lactose
competeswithGRGforbindingtogal-1.Thissuggeststhatweare
dealing with only one major mode of interaction.
The GRG-binding domain includes residues from the quintes-
sential lactose binding site (H44, N46, R48, H52, N61, W68,
usingtheone-letteraminoacidcode),aswellasothersthatextend
out from that site down towards the gal-1 dimer interface. These
residues are shown for one gal-1 subunit in Figure 3(B), along
with the lactose molecule to illustrate proportional size of the
binding domain to the disaccharide. This amino acid composition
is similar to that of the lactose-binding site and suggests the
potential for similar types of protein–glycan interactions, namely
hydrogen bonding and hydrophobic interactions, as well as
electrostatic interactions between or among positively charged
lysine residues (K28, K127 and K129) from gal-1 and negatively
charged galactouronate carboxylate groups from the backbone of
GRG.
HSQC mapping with lactose
Lactose is the quintessential ligand for any galectin. For this
reason, we performed the same gal-1
15N HSQC titration
experiment with lactose. As lactose was titrated (1–10 mM) into
solution, we observed that a number of gal-1 HSQC cross-
peaks were signiﬁcantly chemically shifted by the presence of
lactose, with saturation being achieved by about 5 mM lactose.
Figure 4(A) overlays two HSQC spectral expansions for pure
gal-1 (black) and gal-1 plus 5 mM lactose (red).
15N–
1H weighted
chemical-shift changes against the amino acid sequence of gal-1
are plotted in Figure 4(B). The simple average over all changes is
0.05 p.p.m.Althoughagoodnumberofgal-1residuesareaffected
by lactose binding, those residues that are affected most (mean+
1 S.D.) are highlighted in red on the surface of the gal-1 dimer
in Figure 4(C). (Here we used the same surface orientation as
illustrated for GRG binding in Figure 3.) Other gal-1 residues
that fall above the simple average are highlighted in orange.
As expected, the most affected residues are around the lactose-
binding site identiﬁed previously from X-ray-crystallographic
studies[24],andtheseincludemanyofthesameresiduesaffected
by GRG binding to gal-1.
Interestingly, lactose binding also elicits an effect on residues
at the back side of gal-1 (see Figure 4C), and these are among
those also affected by GRG binding (see Figure 3A, right-hand
image). Because these residues are relatively well removed from
the lactose-binding site, it appears that lactose binding induces
conformational changes, however minor, in other regions of the
folded protein. This observation with lactose supports the idea
that GRG binding to the front face of gal-1 (Figure 3A) does the
same.
To determine the Kd for lactose binding to gal-1, we plotted the
fractional changes in
15N–
1H weighted chemical shifts for the
15 most shifted resonances as a function of the lactose
concentration (Figure 4D). The continuous line represents a
sigmoidal (Boltzmann) ﬁt using the general equation y=A·e
x/b,
through the average value at each concentration point. The χ
2
value for the ﬁt was <0.0005. A microscopic Kd value of
520×10
−6 M was determined from the lactose concentration
at the fractional change of 0.5 (50% bound) and a statistical
correction for the number of lactose binding sites, i.e. two in
the dimer. Our Kd value is similar to that of 330×10
−6 M
reported from calorimetric studies for lactose binding to human
gal-1 at 30◦C [24] and somewhat higher than that reported for
lactose binding to bovine gal-1 (170×10
−6 Ma t3 0 ◦C) [25].
Nevertheless, these values are all in the same range, and any of
theseKd valuesforlactosebindingtogal-1isconsiderablygreater
than the average value we found for gal-1 binding to GRG. The
differenceinKd valuesisconsistentwiththesigniﬁcantresonance
broadening we observed with gal-1 binding to GRG, placing the
interaction in the intermediate exchange regime on the chemical-
shift time scale [22]. In the case of lactose binding to gal-1, we
observed that gal-1 resonances were merely chemically shifted
during the titration with lactose, which is what one would expect
with fast exchange on the chemical-shift time scale.
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Figure 4 HSQC chemical-shift mapping for lactose binding to gal-1
(A)T w o15N–1H HSQC spectra of gal-1 (1mg/ml) are overlayed, one without lactose (black cross-peaks) and one with 5 mM lactose (red cross-peaks). Some of the cross-peaks have been labelled,
as discussed in the text. Resonances are labelled with assignments reported by Nesmelova et al [17]. H1, 1H; N15, 15N. (B) 15Na n d1H weighted chemical-shift changes between pure gal-1 and
gal-1 upon addition of 5mM lactose are plotted against the amino acid sequence of gal-1. The broken line indicates the simple average over all values. (C) Residues on the folded structure of gal-1
that have been most shifted by binding to lactose are highlighted in red and orange as discussed in the text. The X-ray structure of lactose-bound human gal-1 has been used in this Figure (Protein
Data Base access code: 1gzw) [24]. The orientation at the left shows the face of the dimer where lactose binds. The orientation at the right shows the opposite side of the dimer where lactose binds.
(D)Thefractionalchangeingal-1HSQCweightedchemicalshiftsisplottedagainsttheconcentrationoflactose.Thecontinuouslinerepresentsasigmoidal(Boltzmann)ﬁtusingthegeneralequation
y =A ·ex/b through the average value at each concentration point. The χ2 value for the ﬁt was <0.0005.
Gal-β((1→4)-Gal binds gal-1
Even though we demonstrated that gal-1 binds GRG, the
terminal motifs of GRG to which gal-1 most likely interacts are
Gal-β(1→4)-Gal.Galectin/saccharide-bindingdogma,however,
would say that gal-1 would not bind to a Gal-β(1→4)-Gal
motif, primarily because of the axial C
4 hydroxy group on the
reducing-end Gal unit. In lactose [Gal-β(1→4)-Glc], the Glc C
4
hydroxy group is equatorial. For this reason, we performed the
gal-1
15NHSQCtitrationwiththedisaccharideGal-β(1→4)-Gal
and found that gal-1 HSQC cross-peaks are chemically shifted as
they were upon titration with lactose, indicating interaction of
Gal-β(1→4)-Gal with gal-1.
Figure 5(A) indicates which residues in gal-1 are most affected
upon binding Gal-β(1→4)-Gal. If we correlate these chemical-
shift changes with those from the binding of lactose (Figure 4B),
we get a linear regression coefﬁcient of 0.82 (Figure 5B, inset),
which indicates that Gal-β(1→4)-Gal interacts primarily at the
same site on gal-1 as lactose. In Figure 5(B) we plot the fraction
boundforthe20mostchemicallyshiftedgal-1resonancesagainst
the concentration of the disaccharide. For this, we assumed
that saturation occurs by about 10 mM Gal-β(1→4)-Gal, and
set this value as a bound fraction of 1.0. The continuous line
represents a sigmoidal (Boltzmann) ﬁt using the general equation
y=A·e
x/b through the average value at each concentration point.
The χ
2 value for the ﬁt was <0.0005. A microscopic Kd value
of 1200×10
−6 M was determined at the fractional change of 0.5
(50% bound). This Kd value is signiﬁcantly greater than that
for lactose (520×10
−6 M), indicating weaker binding of Gal-
β(1→4)-Gal to gal-1.
From the glycan side
In our NMR experiments we actually observe an average effect
from GRG glycans that vary in size [9] and from which we
cannot get structural detail. Therefore, we performed PFG NMR
diffusion experiments to derive D values for insight into what
occurs from the perspective of the glycan when it binds gal-1.
Forthemostpart,changesinDvaluesreﬂectchangesinmolecular
size (apparent molecular mass and hydrodynamic radius) and/or
solution viscosity due to intermolecular interactions among
glycans. A smaller D value indicates an increase in molecular
size and/or viscosity and vice versa.
For these diffusion experiments we used a ﬁxed concentration
of GRG (4.6 mg/ml) and titrated gal-1 into the glycan solution.
During the titration, D values were acquired for the most intense
GRG resonances, as identiﬁed in the
1H NMR spectral trace
of the glycan preparation shown in Figure 6(A). If this were a
pure single-size glycan, individual resonances would represent
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Figure 5 1H-15N HSQC of gal-1 with and without Gal-β(1→4)-Gal
(A) The histogram shows fractional changes in gal-1 (1mg/ml) HSQC resonance intensities
observed at a Gal-β(1→4)-Gal/gal-1 molar ratio of 4:1 (where most gal-1 resonances are
still apparent) plotted against the amino acid sequence of gal-1. A value of 1 indicates that the
resonance associated with that particular residue is no longer apparent, and a value of zero
indicates no change in resonance intensity. (B) The fractional change in gal-1 HSQC resonance
broadeningisplottedagainsttheconcentration(mg/ml)ofGal-β(1→4)-Gal.Variationamong
these fractional values arises because of differential broadening, in that some resonances are
affectedmorethanothersatdifferentpointsduringthetitration.Thecontinuouslinerepresentsa
sigmoidal (Boltzmann) ﬁt using the general equation y =A ·ex/b, through the average value at
eachconcentrationpoint.Theχ2 valuefortheﬁtwas<0.0005.Theinsetto(B)correlatesHSQC
chemical-shift changes of gal-1 resonances for binding of lactose and Gal-β(1→4)-Gal with
gal-1. The continuous line represents a linear ﬁt to these points, with a regression coefﬁcient of
0.82.
different chemical groups within the GRG molecule and D
values derived from any given resonance should be the same
or very nearly the same (e.g. differences in internal motions of
glycan side chains could affect D). Here, this is not the case,
because our GRG preparation is composed of heterogeneous
galactorhamnogalacturonates, with a distribution of molecular
sizes and a weight-average molecular mass of about 120 kDa
[9]. Moreover, even though chemical shift is not a function of
molecular mass, it is a function of, e.g. chemical composition,
folding and supramolecular structure, i.e. anything that affects
the chemical environment of a particular saccharide residue.
Therefore, depending upon which GRG resonance, or even upon
which point within a resonance envelope, D values can and will
vary because of both these factors and experimental error. It is for
Figure 6 Diffusion decay curves for the titration of gal-1 with GRG
DiffusiondecaycurvesforGRGresonancese(B)andf(C)areshown.Theglycanconcentration
was held constant at 4.6mg/ml, and gal-1 was titrated into solution. Broken lines show
extrapolation to the Y-intercept of the slow component of the decay curve, as discussed in the
text. A 1H-NMR spectral trace for GRG is shown above the plot (A), with resonances labelled as
discussed in the text.
this reason that we measured diffusion-mediated decay curves for
several of the GRG resonances.
To show data quality and give a feel for experimental error,
Figures 6(B) and 6(C) show diffusion decay curves for two
GRG resonances (e and f) as a function of gal-1 concentration.
In the absence of gal-1, diffusion decay curves for these
resonances appear linear (albeit with different slopes; results not
shown), indicating the presence of either a single molecular-
size component for each or any number of different glycan
components with nearly the same molecular size. Decay curves
become increasingly curvilinear as gal-1 is titrated into the GRG
solution.Ifwedeconvoluteeachdecaycurveintotwocomponents
simply by approximating slopes for initial and ﬁnal parts of the
decaycurves,wecanestimateDvaluesforthefastandslowdecay
components. Broken lines are shown through the ﬁnal six to
eight points of the curves to indicate the slow decay components.
Linear ﬁts to these data points are very good, with regression
coefﬁcients greater than 0.9. In this regard, differences in D
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Figure 7 D values for GRG
(A)SomeD valuesfortheslowcomponentofthedeconvoluteddiffusiondecaycurvesareplotted
against gal-1 concentration. (B)O t h e rD values for the slow component of the deconvoluted
diffusion decay curves are plotted against gal-1 concentration. (C) Estimation of the fraction of
the slow decay component by linearly extrapolating the slow component line to the Y-intercept
is shown. These fractions yield the fraction of gal-1-bound glycan.
values are primarily the result of differences in apparent size
of the glycan’s internal ﬂexibility and solution viscosity, as
opposed to experimental error. The fractional contribution of
these slow components to the full decay curves was estimated
from the Y-intercept of the linearly extrapolated curves (broken
lines).
In Figure 7, D values derived from the slow decay components
are plotted as a function of gal-1 concentration. Two types of
trends are observed. For some resonances (a, c, e, and i), D values
initially decrease upon addition of gal-1, and then they increase
somewhat and remain essentially constant (Figure 7A). In the
second set (f, g and h), D values merely increase and plateau
upon addition of gal-1 (Figure 7B). For the ﬁrst set, the initial
decrease in D indicates an increase in molecular size of GRG
uponbindinggal-1,asopposedtoanincreaseinsolutionviscosity.
If solution viscosity were responsible for the initial decrease in
D, the second set would have behaved similarly, and it did not.
If anything, the immediate increase in D values in the second
set indicates that solution viscosity is decreased and/or internal
ﬂexibility is decreased. Moreover, this trend in the second set
suggeststhatGRG glycansassociatedwith Dvaluesderivedfrom
resonancesf,gandheitherdonotbindgal-1orresponddifferently
to interactions with gal-1.
The initial decrease in D occurs at gal-1 concentrations below
1 mg/ml, where gal-1 binding sites on GRG (4.6 mg/ml) are not
fully occupied (vis-` a-vis Figure 2). As the gal-1 concentration is
increased above 1 mg/ml, more and more binding sites on GRG
become occupied such that the apparent molecular size of the
complex should increase, and yet we observe an increase in D
values, indicating the opposite. There are two likely explanations
for this apparent conundrum: (1) gal-1 binding disrupts the
extensive inter-glycan networks that contribute to the normally
high solution viscosity of these polysaccharide solutions; and
(2) the hydrodynamic radius of the glycan is decreased by
gal-1 binding. In either case, gal-1 binding appears to alter
GRG conformation and perturb inter-glycan interactions. Note
that, upon gal-1 binding, the fraction of the GRG slow decay
component is decreased and tends towards a limiting value
(Figure 7C), consistent with saturation of the gal-1-binding sites
on GRG (Figures 2 and 7A/7B). Some slow-component fractions
are decreased more than others, suggesting different extents of
the effect(s) from gal-1 binding.
This gal-1-induced re-organization or conformational change
of the GRG glycan network apparently leads to release of lower-
molecular-size glycan species, as evidenced by trends in D values
derivedfromthefastcomponentsofthedecaycurves(Figure8A).
If we assume that only two glycan components are represented
in each curvilinear decay curve, then the fraction of the fast
component can be estimated by subtracting from one the fraction
of the slow component (Figure 7B), as plotted in Figure 8(B).
During the titration with gal-1, the fraction of the fast component
increases rapidly up to the gal-1 saturation point (about 1 mg/ml)
and then tends to level off at anywhere from about 20 to 50%
of the total glycan species reﬂected in D values derived from that
resonance. On the basis of apparent D values, we estimate
that molecular sizes of galectin-mediated GRG-released glycans
range from about 20 to 200 saccharide units, compared with 500
to2000 unitspriortoadditionofgal-1[9].Thedottedlinelabelled
‘decasaccharide’inFigure8(A)wasdrawnasapointofreference,
because a decasaccharide in dilute solution would have a D value
around 2×10
−6 cm
2/s [9]. It is important to note here, however,
that because our GRG glycans are not in dilute solution, actual
D values will be lower, and changes in D values correlate better
with changes in hydrodynamic radii than with molecular mass
[9]. It is for this reason that we have provided a very wide range
in our estimates of the possible number of saccharide units stated
above. Nevertheless, these ranges are reasonable. Furthermore,
because gal-1 at these concentrations is a dimer with a molecular
mass of 29 kDa, it is unlikely that gal-1 binds to the smallest
glycans with D values near to, or larger than, that for the gal-1
dimer(D=1.04×10
−6 cm
2/s).Ifgal-1weretobindtotheseGRG
glycans, the D values would be signiﬁcantly lower by the end of
the titration, and they are not.
On the basis of these data, we estimate a binding stiochiometry
of 6:1 (gal-1/GRG) by assuming that saturation of GRG
(37×10
−6 M) with gal-1 occurs at a gal-1 concentration of
about 240×10
−6 M (Figures 7 and 8). This stiochiometry is
essentiallythesameasthatderivedfromourHSQCbindingcurve
(Figure2A),whichindicatedabindingstiochiometryofabout5:1
(gal-1/GRG). Nevertheless, the average microscopic dissociation
constants for gal-1 binding to GRG derived either way would
be essentially the same, i.e. 48×10
−6 M at 6:1 compared with
40×10
−6 M at 5:1. This indicates that gal-1 binds to sites on
GRG about 10-fold more strongly than it does to lactose.
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Figure 8 D values for GRG fast component
(A) D values for the fast component of the deconvoluted diffusion decay curves are plotted
against gal-1 concentration. The dotted line labelled ‘decasaccharide’ was drawn as a point
of reference, because a decasaccharide in dilute solution would have a D value of about 2×
10−6cm2/s[9].(B)Estimationofthefractionofthefastdecaycomponentbylinearlyextrapolating
the slow component line to the Y-intercept is shown. This estimation assumes that the decay
curve is composed of only two glycan fractions.
DISCUSSION
We report here several ﬁndings that increase our understanding
of how gal-1 interacts with larger, more complex, glycans, in
the present case with a pectin-derived GRG, galactorhamno-
galacturonate. First of all, we found that gal-1 binds relatively
strongly to GRG glycans (microscopic Kd ≈40×10
−6 M), more
so than it does to lactose (Kd ≈520×10
−6 M). The multivalent
nature of GRG (ﬁve or six gal-1 CRDs per average glycan
molecule) contributes to this greater afﬁnity or avidity for gal-1
(e.g.[6,26,27]),somethingthatisobservedwithmanycell-surface
glycoconjugates that bear multiple galectin-binding sites [28].
The corresponding free energies for binding of GRG glycans and
lactose are 6.08 kcal/mol and 4.54 kcal/mol (1 kcal=4.184 kJ)
respectively,which(assumingasinglemodeofinteraction)reﬂect
the greater surface area on gal-1 with which GRG interacts,
approx. 1600 Å
2 (1 Å=0.1 nm) compared with 700 Å
2 for the
much smaller disaccharide lactose.
The larger binding region on gal-1 GRG not only includes
residues of the lactose-binding domain, but extends from there
through a broad valley or cleft towards the dimer interface.
From the overall dimensions of the protein surface, we estimate
that this binding domain could accommodate about eight to ten
saccharide units, a number that is consistent with the up to 20 or
so saccharide units present in any of the multiple oligosaccharide
branches of GRG. Moreover, the amino acid composition of
the binding domain is consistent with promotion of protein–
glycan interactions, as it contains a signiﬁcant number of polar
residues that could potentially form hydrogen bonds with polar
groups from the glycan. In addition, negatively charged groups
are absent from this domain, whereas positively charged amino
acid residues are present for potential electrostatic interactions
with negatively charged galacturonate carboxylate groups in the
backbone of GRG, as has been reported to occur with the binding
of sulfated glycosaminoglycans to platelet factor-4 or sulfated
galactosaminoglycans to other galectins [29,30].
Although we do not know which speciﬁc groups on GRG
are involved in interactions with gal-1, galectins are generally
known for their ability to bind to β-galactosides [1]. GRG is
composed of about one-third galactose units, which are in either
α(1→4) or β(1→4) anomeric linkages. However, most of these
arefoundintheglycanbackbone,mainlyassectionsofα-(1→2)-
L-rhamnosyl-α-(1→4)-D-galacturonosyl, and it is unlikely that
these galactose units would be accessible to bind to gal-1, as, for
example, branched saccharide side chains would likely interfere
sterically with the interaction. On the other hand, GRG contains
terminalβ(1→4)-galactoseunits,whichweproposearelikelyto
be involved in interactions with gal-1. This suggestion, however,
poses a problem in that these terminal units exist in a Gal-
β(1→4)-Gal motif to which gal-1 should not bind because,
unlike lactose [Gal-β(1→4)-Glc], the reducing-end saccharide
(galactose) has an axial (not equatorial) C
4 hydroxy group.
Nevertheless, our HSQC data demonstrate that Gal-β(1→4)-
Gal does bind at the gal-1 lactose-binding site, albeit not as
strongly. Manual docking of Gal-β(1→4)-Gal into the lactose-
binding site on gal-1 in silico suggests that this galactose C
4
axial hydroxy group would be sterically hindered only by the side
chainofR48(Arg
48)fromgal-1,andthataconformationalchange
in the R48 side chain could alleviate most of the unfavourable
steric hindrance. In support of this, Lefﬂer et al., who have done
extensive work with galectin-binding oligosaccharides (see, e.g.,
[31,32]) reported that the gal-1 carbohydrate-binding domain can
tolerate many chemical modiﬁcations and extensions, both linear
andbranched.Ourobservationmayalsoberelevanttomammalian
glycobiology, as β-D-galactose is the terminal saccharide unit
found in 23% of all mammalian glycans [33], and their terminal
β-D-galactose units would be linked in a similar fashion.
Even if terminal β(1→4)-galactose on GRG were part of the
gal-1-binding epitope, GRG is a heterogeneous glycan, and there
could be multiple modes of interaction. Four points, however,
support the idea that there is one major mode of interaction:
(1) during the gal-1 HSQC titration with GRG, resonance broad-
eningforallresiduesfollowedessentiallythesametitrationcurve;
(2) most residues affected by the presence of GRG are located
over a contiguous surface of the folded protein; (3) the binding
strength, i.e. Kd, that we observe would likely not be as great
if there were numerous smaller binding patches interacting in
multiple ways; and (4) lactose competes with gal-1 for binding to
GRG.Nevertheless,althoughwecannotexcludethepossibilityof
morethanonemodeofbinding,themoreimportantmessagefrom
our data is that GRG (and likely other larger glycans) can interact
with the surface of gal-1 over a larger region than previously
thought from studies with small simple saccharides [34–38].
We also found that gal-1 interactions with GRG attenuate
inter-glycan interactions. By forming large intermolecular net-
works, glycans generally exhibit highly increased solution
viscosity. For example, Daas et al. reported that, because of
their high hydrodynamic volume, polysaccharides, even at low
concentration, can form viscous solutions [39]. We demonstrated
this previously with GRG by measuring D as a function of GRG
concentration, such that, as the concentration was lowered, D
values increased [9]. In the present study we observed that the
D value for GRG initially decreases in some instances, simply
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increases in others, but nevertheless eventually increases in all
cases as gal-1 is titrated into the GRG solution. Since we know
thatgal-1interactswithGRG,themostreasonableexplanationfor
increasing D values is that gal-1 binding decreases the apparent
solution viscosity, which most likely occurs via attenuation of
inter-glycaninteractions.Althoughitisunclearhowthisoccursat
themolecularlevel,wesuggestthatgal-1bindssaccharidegroups
that would otherwise be involved in intermolecular inter-glycan
interactions and that gal-1 binding somehow re-conforms
glycan molecules to promote their dissociation. A common
analogy would be decongesting a trafﬁc jam or nasal blockage.
Gal-1-mediated glycan decongestion may be biologically
relevant. Glycans, in one form or another (glycoproteins
or glycolipids), are a major component of any cell-surface
micro-environment, and the glycan concentration within micro-
environments can be quite high. In fact, we can estimate the
glycan concentration in situ. At least for engineered glycan-
containing mucins in a plasma membrane, cell-surface packing
density is about 50 molecules/μm
2 [40,41]. Assuming that the
glycan moieties of each mucin extend about 100×10
−10 m
from the membrane surface to deﬁne the volume of each
m o l e c u l e ,w ew o u l dh a v e8 ×10
−23 mol per 1×10
−17 litre, or
a concentration of about 8×10
−6 M. Considering that there are
numerous glycoproteins on a typical cell surface, this estimate
seems reasonable and may even be low, because glycoproteins
are not generally homogeneously dispersed on the cell surface
(as assumed in our estimation) and are often found in plasma-
membrane microdomains [42,43]. Therefore, the concentration
of some glycoproteins (and their associated glycans) can be
relatively high, possibly in the micro- to milli-molar range, as
used here in vitro with GRG.
The functional relevance of galectin-mediated glycan decon-
gestion is further supported by the observation that gal-1
interactionswithcell-surfaceglycansincreasemembraneﬂuidity.
Gupta et al. used EPR spectroscopy to demonstrate that gal-1 (in
a concentration-dependent manner from 1.1 to 4.4 μM) increases
erythrocyte membrane ﬂuidity up to a factor of about 3-fold
[44]. In this regard, cell-surface viscosity should be decreased, as
ﬂuidityisinverselycorrelatedwithviscosity.Increasedmembrane
ﬂuidity may be necessary for cell-surface glycoproteins to re-
organizewithintheplasmamembrane,asisrequired,forexample,
for cell adhesion [45]. Confocal microscopy has demonstrated
that, upon exposure to gal-1, CD45 and CD43 receptors cluster
on the cell surface of MOLT-4 cells (leucocytes) within 20 min
upon exposure to gal-1 [43]. A similar observation has been
made with gal-3, which associates and forms clusters when it
interactswithcell-surfaceglycans,therebyexplainingitsabilityto
mediatereorganizationofcell-surfaceglycoproteins[46].Inthese
studies, cell-surface glycoprotein re-organization and clustering
are triggered by gal-1–glycan (glycoconjugate) binding and,
given the limited time scale over which this process occurs, the
phenomenon is likely primarily physically driven. A number of
other studies have also proposed that binding of various galectins
(i.e. gal-1, -3, -4 and -9) to speciﬁc cell-surface glycoproteins
contributes to plasma-membrane microdomain assembly and/or
maintenance [47–52].
In the light of our present ﬁndings, we propose that cell-surface
re-organization of glycoconjugates into plasma-membrane
microdomains may be promoted by galectin-mediated glycan
decongestion. Even though the nature of inter-glycan interactions
(speciﬁc or non-speciﬁc) among various glycoconjugates on the
cell surface is unknown, these interactions do occur and would
likely attenuate lateral diffusion of glycoproteins and glycolipids
within the cell membrane. Galectin interactions with cell-
surface glycoproteins may then promote glycan decongestion,
increase membrane ﬂuidity and thereby allow glycoconjugate re-
organization within the cell membrane to occur.
Conclusions
In the present study we used NMR spectroscopy to investi-
gate interactions between gal-1 and a heterogeneous galacto-
rhamnogalacturonate, GRG. We found that GRG binds to gal-
1 more strongly than lactose, and over a broader area on the
protein surface, which runs from the quintessential lactose-
binding site through a broad valley towards the dimer interface.
This information expands our view of how galectins in general
may interact with glycans in situ, and this may play a role in
determining and/or differentiating galectin function. Moreover,
we found that gal-1 binding to the glycan acts to decongest
inter-glycan interactions. Because of this ﬁnding, our cell-surface
glycan decongestion hypothesis may be biologically relevant in
that glycan decongestion could promote re-organization of cell-
surface glycoconjugates into plasma-membrane microdomains.
Overall, our results provide an insight into galectin function
in situ and may help explain how gal-1 mediates cell–cell and
cell–matrix adhesion and migration.
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